AKT1 and Merkel cell skin cancer: Altogether, these data suggest that MeSG treatment on VP-MCC cells can regulate the PI3K/AKT and MAPK signaling pathways and lncRNAs to restrict cell growth and induce apoptosis, demonstrating the promise of schweinfurthin as a therapeutic agent for MCC (Figure 5E).